Bridgefront Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,070
| Closed | -$636K | – | 596 |
|
|
2025
Q1 | $636K | Buy |
+29,070
| New | +$636K | 0.18% | 186 |
|
|
2023
Q4 | – | Sell |
-6,802
| Closed | -$259K | – | 368 |
|
|
2023
Q3 | $259K | Buy |
6,802
+4,175
| +159% | +$159K | 0.18% | 249 |
|
|
2023
Q2 | $239K | Buy |
+2,627
| New | +$239K | 0.13% | 333 |
|
|
2021
Q3 | – | Sell |
-3,390
| Closed | -$214K | – | 326 |
|
|
2021
Q2 | $214K | Sell |
3,390
-1,289
| -28% | -$81.4K | 0.08% | 484 |
|
|
2021
Q1 | $201K | Buy |
+4,679
| New | +$201K | 0.06% | 587 |
|